Finkelstein Thompson LLP Announces Investigation of American Realty Capital Trust, Inc.15:38 EDT Monday, September 10, 2012 WASHINGTON (Business Wire) -- The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of American Realty Capital Trust, Inc. (“American Realty” or the “Company”) (NASDAQ: ARCT), concerning the proposed acquisition of the Company by Realty Income Corp. (“Realty Income”) (NYSE: O). Under the terms of the transaction, American Realty shareholders would receive .2874 shares of Realty Income for each share of American Realty they own. The current value of the per-share consideration is approximately $12.23, and the total value of the transaction is approximately $2.95 billion. American Realty has performed well recently, reporting improved financial results in its filings with the SEC. At least one analyst has set a target price of $13.00 for the Company's shares. The investigation is focused on the potential unfairness of the consideration to American Realty shareholders, the process by which the Company's Board of Directors considered the transaction, and potential conflicts of interests among American Realty Board members. If you are interested in discussing your rights as a American Realty shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at contact@finkelsteinthompson.com. Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers. To learn more about Finkelstein Thompson LLP, please visit our web site at www.finkelsteinthompson.com. Attorney advertising. Prior results do not guarantee similar outcomes. Finkelstein Thompson LLPRichard M. Volin, 877-337-1050